Biomarkers in Cardiovascular Disease: Utility in Diagnosis, Risk Assessment, and Therapy

被引：1
|
作者：
Apple, Fred S. [1 ,2 ]
Daniels, Lori B. [3 ]
Mills, Nicholas L. [4 ,5 ]
Nordestgaard, Borge [6 ,7 ]
机构：
[1] Hennepin Healthcare HCMC, Dept Lab Med, Minneapolis, MN USA
[2] Hennepin Healthcare HCMC, Dept Pathol, Minneapolis, MN USA
[3] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[4] Univ Edinburgh, BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland
[5] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland
[6] Copenhagen Univ Hosp, Dept Clin Biochem, Herlev & Gentofte Hosp, Herlev, Denmark
[7] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
来源：
CLINICAL CHEMISTRY | 2021年 / 67卷 / 01期
关键词：
CARDIAC TROPONIN;
D O I：
10.1093/clinchem/hvaa295
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [1] The Utility of Emerging Biomarkers and Imaging for Assessment of Cardiovascular Risk
    Gallino, Augusto
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (06) : 712 - 714
  • [2] Menopausal Hormone Therapy and Cardiovascular Disease Risk: Utility of Biomarkers and Clinical Factors for Risk Stratification
    Bassuk, Shari S.
    Manson, JoAnn E.
    [J]. CLINICAL CHEMISTRY, 2014, 60 (01) : 68 - 77
  • [3] Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification
    Bassuk, Shari S.
    Manson, JoAnn E.
    [J]. BIOCHIMICA CLINICA, 2015, 39 (02) : 141 - 151
  • [4] The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease
    Lewis, James D.
    [J]. GASTROENTEROLOGY, 2011, 140 (06) : 1817 - U160
  • [5] Clinical utility of novel biomarkers for cardiovascular disease risk stratification
    Maurizio Averna
    Davide Noto
    [J]. Internal and Emergency Medicine, 2012, 7 : 263 - 270
  • [6] Clinical utility of novel biomarkers for cardiovascular disease risk stratification
    Averna, Maurizio
    Noto, Davide
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2012, 7 : S263 - S270
  • [7] The role of cardiac biomarkers in cardiovascular disease risk assessment
    Collinson, Paul
    [J]. CURRENT OPINION IN CARDIOLOGY, 2014, 29 (04) : 366 - 371
  • [8] Utility of Cardiovascular Imaging to Refine Cardiovascular Disease (CVD) Risk Assessment
    Marcio Sommer Bittencourt
    Edward A. Hulten
    Khurram Nasir
    Ron Blankstein
    [J]. Current Cardiovascular Risk Reports, 2014, 8 (4)
  • [9] Utility of Cardiovascular Imaging to Refine Cardiovascular Disease (CVD) Risk Assessment
    Bittencourt, Marcio Sommer
    Hulten, Edward A.
    Nasir, Khurram
    Blankstein, Ron
    [J]. CURRENT CARDIOVASCULAR RISK REPORTS, 2014, 8 (04)
  • [10] Novel and Emerging Biomarkers with Risk Predictive Utility for Atherosclerotic Cardiovascular Disease
    Shah N.N.
    Rohatgi A.
    [J]. Current Cardiovascular Risk Reports, 2018, 12 (3)
12345